About Dr. Sanjiv Saigal
Dr. Sanjiv Saigal is a globally recognized liver transplant and hepatopancreatobiliary (HPB) specialist with over two decades of clinical experience. Having contributed to more than 3,400 liver transplants, he is known for his expertise in managing complex liver conditions such as acute liver failure, liver cancer, and re-transplantation cases. Dr. Saigal’s approach is rooted in evidence-based, multidisciplinary care, combining the skills of hepatologists, oncologists, and transplant surgeons to deliver the best possible outcomes. In addition to his clinical excellence, he plays an active role in medical education, research, and international transplant collaborations, ensuring ongoing advancement in liver care.
To consult Dr. Sanjiv Saigal, international and domestic patients can book appointments easily through CancerRounds, which offers end-to-end support for both local and overseas cases.
- MBBS, 1989, MBBS (Gold Medalist) - Calcutta National Medical College and Hospital
- MD (Internal Medicine), PGIMER Chandigarh, 1991-94
- MAMS, 2010, Royal College of Physicians, London
- MRCP, 1999, Royal College of Physicians, London
- DM (Gastroenterology), Govind Ballabh Pant Hospital, University of Delhi, 1995-98
- DNB, 1996, National Borad of Examinations Ministry of Health Government of India
- MRCP – Royal College of Physicians, Edinburgh (1999)
- Liver Transplant Fellowship – King’s College Hospital, London (1999–2001)
- CCST – Certificate of Completion of Specialist Training in Gastroenterology, UK (2005)
- American Association for the Study of Liver Diseases (AASLD)
- International Liver Transplantation Society (ILS) – Founding Member; Education Committee Member
- Liver Transplantation Society of India – Vice President (2020)
- Asia-Pacific Association for the Study of the Liver (APASL)
- MAMS (Membership), National Academy of Medical Sciences, New Delhi (2010)
- Indian Association for the Study of Liver (IASL); Indian Society of Gastroenterology; Indian Medical Association.
- Liver Cirrhosis
- Portal Hypertension
- Acute-on-Chronic Liver Failure (ACLF)
- Viral Hepatitis (Hepatitis B & C)
- Non-Alcoholic Fatty Liver Disease (NAFLD/NASH)
- Alcoholic Liver Disease
- Hepatocellular Carcinoma
- Cholangiocarcinoma
- Liver Transplantation – Adult living-donor and deceased-donor transplants with >90% success rates
- Hepato-Pancreato-Biliary (HPB) Surgery – Advanced surgeries for liver, pancreas, and biliary tract diseases
- Endoscopic & Interventional Hepatology – Pancreatobiliary endoscopy and non-invasive liver disease management
- Multidisciplinary Liver Cancer Care – Integrated oncologic care for liver malignancies
- Living & Deceased Donor Liver Transplantation
- Complex HPB Resections (Liver, Bile Duct, Pancreas)
- Endoscopic Retrograde Cholangiopancreatography (ERCP) & EUS-guided procedures
- Management of Post-Transplant Complications
- Portal Hypertension Interventions (TIPS and variceal therapy)
- Principal Director & Head, Hepatology & Liver Transplant Medicine – Max Super Specialty Hospital, Delhi (2021–Present)
- Senior Director – Medanta, Gurgaon (2019–2020)
- Head – Transplant Hepatology & Digestive Sciences – Medanta (2012–2019)
- Consultant Hepatologist – Sir Ganga Ram Hospital, Delhi (2002–2010)
- Clinical Fellow – King’s College Hospital, London (1999–2001)
- 3,400+ Liver Transplants: Among the highest individual counts in India
- Established India’s First Transplant Hepatology Program with integrated donor-recipient care at India
- Mentorship & Leadership: Spearheaded liver transplant programs across top Indian hospitals including Max and Medanta
- Philanthropic Award: Human Care Award (2018); INLAKS Foundation Scholar at King’s College London; National Pfizer Award & Calcutta University Gold Medal l
- Human Care Award (2018)
- National Pfizer Award – For outstanding performance in MBBS or early-career achievements
- First Prize, National Hepatology Quiz (INASL, 2006)
- INLAKS Medical Scholarship for London fellowship (1998)
- Multiple academic distinctions during MBBS (1988)
- “Long‑term Complications of Immunosuppression Post Liver Transplant” R. Mehtani & S. Saigal—J. Clin. Exp. Hepatol., 2023
- “Basics and Art of Immunosuppression in Liver Transplantation” Saigal et al. (collaborative authorship) — J. Clin. Exp. Hepatol., May 2024
- Acute and acute-on-chronic liver failure consensus & outcomes
- Studies on biliary complications post-transplant
- Successful liver transplants in acute liver failure, hepatocellular carcinoma, portal hypertension, and pediatric cases
- R. Bala – Delhi, India - We met Dr. Sanjiv Saigal for my father’s liver-related condition. He took the time to explain the diagnosis in a way we could easily understand. There was no rush, and the whole consultation felt respectful and thorough. We felt more at ease after speaking with him.
- Kavita S. – Gurgaon, India - My wife was having persistent digestive symptoms, and we were unsure about the cause. Dr. Saigal listened carefully and suggested only the necessary tests. Thankfully, it wasn’t anything serious. His calm and clear approach really helped reduce our anxiety.
- Arif Qureshi – Lucknow, India - I was referred to Dr. Saigal for a second opinion. He didn’t dismiss our concerns but instead reviewed every report patiently. What I appreciated most was his honest feedback—he gave us clarity without pushing unnecessary treatments.
Treatment Type | Cost Range (INR) | Cost Range (USD) |
Adult Liver Transplant – starting package | 20,00,000 - 26,50,000 | 23,411 - 31,019 |
Living Donor Liver Transplant | 20,00,000 - 26,00,000 | 23,411 - 30,434 |
Deceased Donor Liver Transplant | 22,00,000 - 27,50,000 | 25,752 - 32,190 |
Split/Auxiliary/Pediatric Transplants | 20,24,000 - 22,80,000 | 23,692 - 26,688 |
- Medical visa processing and invitation letters
- Airport pickup and local transportation
- Hotel/hospital accommodation arrangements
- Coordination with embassies and insurance providers